Day: December 5, 2025

Boca Raton, FL, Dec. 05, 2025 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB) (“INmune” or the “Company”), a clinical-stage inflammation and immunology company, announces a recently published overview of future applications and research areas for mesenchymal stromal cell (MSC) therapies, such as INmune’s CORDStrom™ platform. The article, titled, “Fate and Function of Exogenously Administered MSCs: Current Insights and Future Directions,” was published in the peer-reviewed journal Cytotherapy. One of the lead authors of the paper was INmune Bio’s lead scientist for CORDStrom™ R&D, Dr Nikita M. Patel, M.Sci.,Ph.D. The article, was the result of an invitation-only working party of basic, clinical and translational scientists working on MSCs and available on Cytotherapy’s website, reviews the current knowledge-base...

HOTEL101-NISEKO WITH ITS 1.17 HECTARE PRIME SITE AND 482 ROOMS IS EXPECTED TO BE ONE OF THE LARGEST HOTELS IN THE HEART OF HIRAFU, NISEKO, HOKKAIDO, JAPAN BY ROOM COUNT, LOCATED ABOUT 2 MINUTES BY SHUTTLE TO THE SKI LIFTS HOTEL101-NISEKO’S TOPPING OFF CEREMONY CONDUCTED TODAY HIGHLIGHTS THE EXPECTED COMPLETION OF THE WHOLE BUILDING STRUCTURE, TO BE FOLLOWED BY THE FULL SWING INTERIOR FINISHING WORKS IN TIME FOR THE EXPECTED HOTEL OPENING IN DECEMBER 2026. HOTEL101-NISEKO’S COMPLETION PROGRESS IS ON SCHEDULEDoubleDragon Corporation Founders Edgar “Injap” Sia II and Tony Tan Caktiong at the Topping Off Ceremony of Hotel101-Niseko held today December 5, 2025DoubleDragon Corporation Founders Edgar “Injap” Sia II and Tony Tan Caktiong with Hotel101 Global CEO Hannah Yulo-Luccini at topmost floor of Hotel101-Niseko project site SINGAPORE,...

VANCOUVER, British Columbia, Dec. 05, 2025 (GLOBE NEWSWIRE) — LEEF Brands, Inc. (CSE: LEEF, OTCQB: LEEEF) (“LEEF” or the “Company”), a leading multi-state operator, today announced the full early conversion of its outstanding 11% secured convertible debentures due September 9, 2027, in principal amount together with accrued and unpaid interest of approximately US$10,588,928. The conversion was completed under amended incentive terms that offered debenture holders the opportunity to settle their debentures into units at a conversion price of CAD $0.25 per unit, with each unit consisting of one common share and one common share purchase warrant exercisable at CAD $0.30 for a period of 36 months. Under the early settlement, approximately 59,209,048 units will be issued. In addition, the Company confirms that Chief Executive Officer...

SCOTTSDALE, AZ, Dec. 05, 2025 (GLOBE NEWSWIRE) — Signing Day Sports, Inc. (“Signing Day Sports” or the “Company”) (NYSE American: SGN) today announced the release of a shareholder letter from its Chairman and CEO, Daniel Nelson. The shareholder letter provides an update on Company management’s perspective of the Company’s proposed business combination with BlockchAIn Digital Infrastructure, Inc. (“BlockchAIn Inc.”) and its affiliate, One Blockchain LLC (“BlockchAIn LLC” and together with BlockchAIn Inc., “BlockchAIn”). As previously announced, Signing Day Sports entered into a Business Combination Agreement with BlockchAIn and certain other affiliates of BlockchAIn on May 27, 2025, as amended on November 10, 2025 (as amended, the “Business Combination Agreement”). Under the Business Combination Agreement, upon the closing of the...

    Stellantis’ Shares to Win Employee Purchase Plan Reaches22 Million Shares Subscribed in Over Three YearsThird consecutive annual edition of Shares to Win completed in 20 countries, representing more than 235,000 eligible employees €209 million invested in the plan since its launch in 2023 Average employee investment in 2025 surpassed €1,150AMSTERDAM, December 5, 2025 – Stellantis’ employee share purchase plan, Shares to Win, completed its 2025 edition on November 25, 2025. Since its launch in 2023, employees have subscribed to 22 million shares. This third consecutive annual edition extended across 20 countries, engaging more than 235,000 eligible employees. An Ambitious Employee Share Purchase Plan Shares to Win perfectly embodies Stellantis’ people-first mindset, aiming to offer its employees the opportunity to be involved...

Baltic Horizon Capital AS, the management company, hereby informs that the subsidiary of the Baltic Horizon Fund BOF Sky SIA has received a notice on the termination of the lease agreement from its tenant Skai Baltija, which operates a shop in the size of approximately 2,600 sq.m in Riga. This termination intention with the effective date at the end of January 2026 is not permitted and is considered without a ground by the management company, as the unbreakable lease terms under valid lease agreement runs until the end of 2029. If necessary, the Fund will dispute this termination in courts and will pursue compensation of any losses the Fund as lessor would be incurring in case this illegal termination is indeed pursued by the tenant. For additional information, please contact: Tarmo KarotamBaltic Horizon Fund managerE-mail tarmo.karotam@baltichorizon.comwww.baltichorizon.com Baltic...

        Company Announcement No 62/2025Peberlyk 46200 AabenraaDenmark Tel +45 74 37 37 37Fax +45 74 37 35 36 Sydbank A/SCVR No DK 12626509, Aabenraasydbank.dk5 December 2025  Dear Sirs All conditions met – the Danish FSA approves merger between Sydbank A/S, Arbejdernes Landsbank and Vestjysk Bank In Company Announcement No 48 dated 27 October 2025, Sydbank A/S announced that Sydbank A/S, Aktieselskabet Arbejdernes Landsbank and Vestjysk Bank A/S had agreed to propose to their respective general meetings that the three banks merge. The merger documents were published in connection with Company Announcement No 52 on 29 October 2025. In Company Announcement No 58 dated 1 December 2025 Sydbank announced that the Danish Competition and Consumer Authority had approved the merger. The merger was approved at the general meetings...

SAN DIEGO, Dec. 05, 2025 (GLOBE NEWSWIRE) — Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics, today announced the pricing of its underwritten public offering of 6,000,000 shares of common stock at a public offering price of $25.00 per share. Capricor also granted the underwriters a 30-day option to purchase up to an additional 900,000 shares of its common stock at the public offering price, less the underwriting discounts and commissions. The offering is expected to close on or about December 8, 2025, subject to the satisfaction of customary closing conditions. The gross proceeds from the offering are expected to be $150 million, before deducting underwriting discounts and commissions and offering expenses payable by Capricor and assuming no exercise...